Secondary prevention of coronary heart disease: Risk factors must be assessed and treatment targets met to prevent patients with coronary heart disease having a further cardiovascular event

View/ Open
Author(s)
Hamilton-Craig, Ian
Griffith University Author(s)
Year published
2009
Metadata
Show full item recordAbstract
Patients with coronary heart disease (CHD) have a more than 20% risk of having a further cardiovascular disease event within five years. 堐atients with CHD should be screened for dyslipidaemia at six to eight weeks after an MI and for diabetes at least eight weeks after an MI. 堄uplex ultrasound can be used to check for carotid, abdominal aortic and femoropopliteal atherosclerosis in patients with CHD. 堉t is standard to give the SAAB regimen (a statin, aspirin, an angiotensin-converting enzyme inhibitor and a beta blocker) to patients who have had an acute coronary syndrome. 堂lood pressure targets in patients with CHD are ...
View more >Patients with coronary heart disease (CHD) have a more than 20% risk of having a further cardiovascular disease event within five years. 堐atients with CHD should be screened for dyslipidaemia at six to eight weeks after an MI and for diabetes at least eight weeks after an MI. 堄uplex ultrasound can be used to check for carotid, abdominal aortic and femoropopliteal atherosclerosis in patients with CHD. 堉t is standard to give the SAAB regimen (a statin, aspirin, an angiotensin-converting enzyme inhibitor and a beta blocker) to patients who have had an acute coronary syndrome. 堂lood pressure targets in patients with CHD are determined by the presence of diabetes, renal dysfunction and proteinuria. 堁ssessment and treatment of depression and social isolation are important in the overall management of patients with CHD.
View less >
View more >Patients with coronary heart disease (CHD) have a more than 20% risk of having a further cardiovascular disease event within five years. 堐atients with CHD should be screened for dyslipidaemia at six to eight weeks after an MI and for diabetes at least eight weeks after an MI. 堄uplex ultrasound can be used to check for carotid, abdominal aortic and femoropopliteal atherosclerosis in patients with CHD. 堉t is standard to give the SAAB regimen (a statin, aspirin, an angiotensin-converting enzyme inhibitor and a beta blocker) to patients who have had an acute coronary syndrome. 堂lood pressure targets in patients with CHD are determined by the presence of diabetes, renal dysfunction and proteinuria. 堁ssessment and treatment of depression and social isolation are important in the overall management of patients with CHD.
View less >
Journal Title
Medicine Today
Volume
10
Issue
1
Publisher URI
Copyright Statement
© 2009 Medicine Today. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
Subject
Cardiorespiratory Medicine and Haematology not elsewhere classified
Medical and Health Sciences